PUBLISHER: KBV Research | PRODUCT CODE: 1245257
PUBLISHER: KBV Research | PRODUCT CODE: 1245257
LAMEA Cluster Headache Market Size, Share & Industry Trends Analysis Report By Distribution channel, By Type (Episodic, and Chronic), By Drug Class (Triptans, Calcium Channel Blockers, Ergot Derivatives), By Country and Growth Forecast, 2022 - 2028
The Latin America, Middle East and Africa Cluster Headache Market would witness market growth of 7.8% CAGR during the forecast period (2022-2028).
The cycle of a headache might be shortened by using prescription drugs. These may lessen the intensity of the headaches. Verapamil, lithium carbonate, divalproex sodium, calcium channel blockers, melatonin, and topiramate are possible treatments. In addition, a new preventative treatment is a monoclonal antibody against the calcitonin gene-related peptide (CGRP). If necessary, cluster headaches have been treated surgically in the past. The use of gentle electrical stimulation on the neck is one approach. Another inserts a medical device through the top gums to produce electrical stimulation.
A rise in the introduction of different monoclonal antibodies for cluster headaches and an increase in the number of novel medications being tested in clinical trials by significant firms are expected to benefit the market's expansion. Also, it is projected that an increase in the number of cluster headache drugs in development would fuel market growth.
Saudi Arabia Pharmaceuticals' mission is to accelerate the development of the region's manufacturing cluster and transition to more complex goods with an emphasis on those crucial for national security. With the total net worth of $120 billion and an excellent export prospect, the Saudi pharmaceutical industry is one of the fastest-growing in the world today. The Saudi pharmaceutical sector grew by over 5% CAGR in 2018 to reach 8.2 billion dollars in sales. Up to 2025, the industry is anticipated to expand at a 5% annual pace to reach $10 Bn. The substantial investment and the growing number of initiatives by the government to develop the pharmaceutical sector will provide innovative and enhanced treatment options for the cluster headache, which will propel the market growth in the LAMEA.
The Brazil market dominated the LAMEA Cluster Headache Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $8.6 Million by 2028. The Argentina market is experiencing a CAGR of 8.3% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 7.5% during (2022 - 2028).
Based on Distribution channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Others. Based on Type, the market is segmented Episodic, and Chronic. Based on Drug Class, the market is segmented into Triptans, Calcium Channel Blockers, Ergot Derivatives, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Dr. Reddy's Laboratories Ltd., Novartis AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline PLC (GSK), Pfizer, Inc., Fresenius SE & Co. KGaA, Eli Lilly And Company, Grunenthal GmbH, and Arrotex Pharmaceuticals Pty Limited.
Scope of the Study
Market Segments covered in the Report:
By Distribution channel
- Drug Stores & Retail Pharmacies
- Hospital Pharmacies
- Others
By Type
- Episodic
- Chronic
By Drug Class
- Triptans
- Calcium Channel Blockers
- Ergot Derivatives
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Dr. Reddy's Laboratories Ltd.
- Novartis AG
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- GlaxoSmithKline PLC (GSK)
- Pfizer, Inc.
- Fresenius SE & Co. KGaA
- Eli Lilly And Company
- Grunenthal GmbH
- Arrotex Pharmaceuticals Pty Limited
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 LAMEA Cluster Headache Market, by Distribution channel
- 1.4.2 LAMEA Cluster Headache Market, by Type
- 1.4.3 LAMEA Cluster Headache Market, by Drug Class
- 1.4.4 LAMEA Cluster Headache Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market composition & scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. LAMEA Cluster Headache Market by Distribution channel
- 3.1 LAMEA Drug Stores & Retail Pharmacies Market by Country
- 3.2 LAMEA Hospital Pharmacies Market by Country
- 3.3 LAMEA Others Market by Country
Chapter 4. LAMEA Cluster Headache Market by Type
- 4.1 LAMEA Episodic Market by Country
- 4.2 LAMEA Chronic Market by Country
Chapter 5. LAMEA Cluster Headache Market by Drug Class
- 5.1 LAMEA Triptans Market by Country
- 5.2 LAMEA Calcium Channel Blockers Market by Country
- 5.3 LAMEA Ergot Derivatives Market by Country
- 5.4 LAMEA Others Market by Country
Chapter 6. LAMEA Cluster Headache Market by Country
- 6.1 Brazil Cluster Headache Market
- 6.1.1 Brazil Cluster Headache Market by Distribution channel
- 6.1.2 Brazil Cluster Headache Market by Type
- 6.1.3 Brazil Cluster Headache Market by Drug Class
- 6.2 Argentina Cluster Headache Market
- 6.2.1 Argentina Cluster Headache Market by Distribution channel
- 6.2.2 Argentina Cluster Headache Market by Type
- 6.2.3 Argentina Cluster Headache Market by Drug Class
- 6.3 UAE Cluster Headache Market
- 6.3.1 UAE Cluster Headache Market by Distribution channel
- 6.3.2 UAE Cluster Headache Market by Type
- 6.3.3 UAE Cluster Headache Market by Drug Class
- 6.4 Saudi Arabia Cluster Headache Market
- 6.4.1 Saudi Arabia Cluster Headache Market by Distribution channel
- 6.4.2 Saudi Arabia Cluster Headache Market by Type
- 6.4.3 Saudi Arabia Cluster Headache Market by Drug Class
- 6.5 South Africa Cluster Headache Market
- 6.5.1 South Africa Cluster Headache Market by Distribution channel
- 6.5.2 South Africa Cluster Headache Market by Type
- 6.5.3 South Africa Cluster Headache Market by Drug Class
- 6.6 Nigeria Cluster Headache Market
- 6.6.1 Nigeria Cluster Headache Market by Distribution channel
- 6.6.2 Nigeria Cluster Headache Market by Type
- 6.6.3 Nigeria Cluster Headache Market by Drug Class
- 6.7 Rest of LAMEA Cluster Headache Market
- 6.7.1 Rest of LAMEA Cluster Headache Market by Distribution channel
- 6.7.2 Rest of LAMEA Cluster Headache Market by Type
- 6.7.3 Rest of LAMEA Cluster Headache Market by Drug Class
Chapter 7. Company Profiles
- 7.1 Dr. Reddy's Laboratories Ltd.
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.2 Novartis AG
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental and Regional Analysis
- 7.2.4 Research & Development Expense
- 7.3 Sun Pharmaceutical Industries Ltd.
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Regional & Segmental Analysis
- 7.3.4 Research & Development Expenses
- 7.4 Teva Pharmaceutical Industries Ltd.
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Regional Analysis
- 7.4.4 Research & Development Expenses
- 7.5 GlaxoSmithKline PLC (GSK)
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Research & Development Expense
- 7.6 Pfizer, Inc.
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Regional & Segmental Analysis
- 7.6.4 Research & Development Expense
- 7.7 Fresenius SE & Co. KGaA
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expenses
- 7.8 Eli Lilly And Company
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Regional Analysis
- 7.8.4 Research & Development Expenses
- 7.9 Grunenthal GmbH
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 Research & Development Expenses
- 7.10. Arrotex Pharmaceuticals Pty Limited
- 7.10.1 Company Overview
LIST OF TABLES
- TABLE 1 LAMEA Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 2 LAMEA Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 3 LAMEA Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 4 LAMEA Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 5 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
- TABLE 6 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
- TABLE 7 LAMEA Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
- TABLE 8 LAMEA Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
- TABLE 9 LAMEA Others Market by Country, 2018 - 2021, USD Million
- TABLE 10 LAMEA Others Market by Country, 2022 - 2028, USD Million
- TABLE 11 LAMEA Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 12 LAMEA Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 13 LAMEA Episodic Market by Country, 2018 - 2021, USD Million
- TABLE 14 LAMEA Episodic Market by Country, 2022 - 2028, USD Million
- TABLE 15 LAMEA Chronic Market by Country, 2018 - 2021, USD Million
- TABLE 16 LAMEA Chronic Market by Country, 2022 - 2028, USD Million
- TABLE 17 LAMEA Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 18 LAMEA Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 19 LAMEA Triptans Market by Country, 2018 - 2021, USD Million
- TABLE 20 LAMEA Triptans Market by Country, 2022 - 2028, USD Million
- TABLE 21 LAMEA Calcium Channel Blockers Market by Country, 2018 - 2021, USD Million
- TABLE 22 LAMEA Calcium Channel Blockers Market by Country, 2022 - 2028, USD Million
- TABLE 23 LAMEA Ergot Derivatives Market by Country, 2018 - 2021, USD Million
- TABLE 24 LAMEA Ergot Derivatives Market by Country, 2022 - 2028, USD Million
- TABLE 25 LAMEA Others Market by Country, 2018 - 2021, USD Million
- TABLE 26 LAMEA Others Market by Country, 2022 - 2028, USD Million
- TABLE 27 LAMEA Cluster Headache Market by Country, 2018 - 2021, USD Million
- TABLE 28 LAMEA Cluster Headache Market by Country, 2022 - 2028, USD Million
- TABLE 29 Brazil Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 30 Brazil Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 31 Brazil Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 32 Brazil Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 33 Brazil Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 34 Brazil Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 35 Brazil Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 36 Brazil Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 37 Argentina Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 38 Argentina Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 39 Argentina Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 40 Argentina Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 41 Argentina Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 42 Argentina Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 43 Argentina Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 44 Argentina Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 45 UAE Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 46 UAE Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 47 UAE Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 48 UAE Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 49 UAE Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 50 UAE Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 51 UAE Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 52 UAE Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 53 Saudi Arabia Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 54 Saudi Arabia Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 55 Saudi Arabia Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 56 Saudi Arabia Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 57 Saudi Arabia Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 58 Saudi Arabia Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 59 Saudi Arabia Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 60 Saudi Arabia Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 61 South Africa Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 62 South Africa Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 63 South Africa Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 64 South Africa Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 65 South Africa Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 66 South Africa Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 67 South Africa Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 68 South Africa Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 69 Nigeria Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 70 Nigeria Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 71 Nigeria Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 72 Nigeria Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 73 Nigeria Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 74 Nigeria Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 75 Nigeria Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 76 Nigeria Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 77 Rest of LAMEA Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 78 Rest of LAMEA Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 79 Rest of LAMEA Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 80 Rest of LAMEA Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 81 Rest of LAMEA Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 82 Rest of LAMEA Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 83 Rest of LAMEA Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 84 Rest of LAMEA Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 85 key information - Dr. Reddy's Laboratories Ltd.
- TABLE 86 Key Information - Novartis AG
- TABLE 87 Key Information - Sun Pharmaceutical Industries Ltd.
- TABLE 88 Key Information - Teva Pharmaceuticals Industries Ltd.
- TABLE 89 Key Information - GlaxoSmithKline PLC (GSK)
- TABLE 90 Key Information - Pfizer, Inc.
- TABLE 91 key information - Fresenius SE & Co. KGaA
- TABLE 92 Key Information - Eli Lilly And Company
- TABLE 93 Key Information - Grunenthal GmbH
- TABLE 94 Key Information - Arrotex Pharmaceuticals Pty Limited
List of Figures
- FIG 1 Methodology for the research
